31 results on '"Lopes-Virella, M F"'
Search Results
2. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease
3. A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases
4. High glucose‐boosted inflammatory responses to lipopolysaccharide are suppressed by statin
5. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study
6. Role of Simvastatin as an Immunomodulator in Type 2 Diabetes
7. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
8. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
9. Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes.
10. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation
11. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects
12. Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes
13. Comparing assays of antibodies to modified low-density lipoproteins
14. Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes
15. Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from Type 1 (insulin-dependent) diabetic patients
16. Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages
17. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.
18. Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic Type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages
19. Serum high density lipoprotein in diabetic patients
20. Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products.
21. Cholesterol determination in high-density lipoproteins separated by three different methods.
22. New approaches to the study of proteinuria.
23. Glycosylation of low density lipoprotein in patients with Type I (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control
24. Rapid immunochemical determination of free hemoglobin in plasma and urine with a laser nephelometer.
25. Early diagnosis of renal malfunction in diabetics
26. Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages
27. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.
28. Immunonephelometric assay of human apolipoprotein AI.
29. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from Type 1 (insulin-dependent) diabetic patients: Changes with metabolic control
30. Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients
31. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.